send to a friend by email

Press release by the PSE: CBPs disclosure of preliminary financials of 2007.

2008-02-12

Palestine securities exchange received the preliminary revised financial statements from the internal auditors of Jerusalem Pharmaceutical Company, as of December 31, 2007. This disclosure came within the applied disclosures system, which grants every listed company a month and a half as utmost period for disclosing the preliminary financial results of 2007. It is revealed by the in formations presented by the CBP that, it had been disclosed using the electronic reporting standard, and a signed paper copy of the internal audited preliminary financials was sent to be verified from the board of directors parallel with another copy that had been sent to the CMA and PSE. Also the annual report of the CBP will be published in March, 2008. As for the general assembly meeting it will be held in March, 2008 to discuss these financial results. This preliminary financials were published on the PSE website as soon as it released by the CBP. CBP"s financial results pointed out to gross income of $352,396 to the year 2007 versus a loss of $79,115 in 2006. Total assets amounted $88,813,639 in 2007 after amounting $79,849,447 in the year 2006. It is also noticed that the total liabilities had soared to amount $ 73,893,138 versus $65,135,644 in the same period of 2006. Shareholders" equity increased in 2007 to $14,920,501 after it had amounted $14,713,803 in 2006.